Sankala Group’s Lam Research LRCX Stock Holding History

Sankala Group’s Portfolio LRCX Stock Details LRCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$66.7K	Buy	206 +10	+5%	+$3.04K	0.04%	223
2026 Q1	$42.2K	Buy	196 +12	+7%	+$2.68K	0.03%	248
2025 Q4	$43.1K	Buy	+184	New	+$28.6K	0.03%	245

Other funds holding LRCX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sankala Group's LRCX Position: Q2 2026 in Review

Sankala Group increased its Lam Research (LRCX) stake by 5.1% in Q2 2026, buying an estimated $3.04K and bringing the position to 206 shares worth $66.7K. The position accounts for 0.04% of the portfolio, ranked #223.

Sankala Group first reported a position in LRCX in Q4 2025 and has held it in 3 quarters since. 3,144 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

Sankala Group held 206 shares of Lam Research worth $66.7K as of Q2 2026.
Sankala Group bought 10 Lam Research shares in Q2 2026, an estimated $3.04K.
Lam Research made up 0.04% of Sankala Group's portfolio in Q2 2026, its #223 holding.
Sankala Group first reported a position in Lam Research in Q4 2025 and has held it in 3 quarters since.
3,144 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Sankala Group's 13F filing for Q2 2026, filed 18 Aug 2026.